64: Androgens Flashcards
GnRH is secreted in a pulsatile fashion every 30-120 min –>
LH release from Pit –>
testosterone release from leydig cells into the blood stream
negative feedback at ant. pit and hypothalamus
leydig cells express ________ that converts androstenedione to testosterone
17B hydroxysteroid dehydrogenase
converts testosterone to dihydrotestosterone
5a reductase
more potent androgen, higher binding affinity
most testosterone in blood is bound to…
albumin or SHBG
the active form is free or bound to albumin
anabolic effects of androgens
- stimulate basal metabolic rate
- inhibit lipid accumulation in adipocyts, stimulates lipolysis, inhibits differentiation of adipocyte precursors
- lowers blood glucose levels by increasing expression of glucose transproters
- reduces bone reabsorption and enhances bone formation
- increases production EPO
- increases prtn synthesis and inhibits prtn breakdown
at puberty, ___ facilitates closure of epiphysial growth plate
estradiol
therapeutic uses androgens
- replacement therapy in hypogonadal men
- aging
- stimulate sexual development and increase height of teenagers with delayed puberty
- severe endometriosis
- debilitated states
causes of primary hypogonadism
- cryptochidism
- klinefelter syndrome
- chemotherapy
testicular dysfunction leading to a decrease in testosterone production. loss of neg. feedback causes an increase in circulating gonadotropins.
hypergonadotropic hypogonadism
low testosterone in the setting of low LH and FSh
secondary hypogonadism
decrease in circulating gonadotrophins from hypo/pit probs or morbid obesity
hypogonadotropic hypogonadism
MOA flutamide, bicalutamide, enzalutamide
competitive antagonists of androgen receptors
used to treat prostate cancer
causes mild gynecomastia
additional effects of enzalutamide
- inhibits nuclear translocation of AR
- blocks DNA binding
- blocks coactivator recruitment
MOA goserelin and leuprolide
GnRH agonists
initially increase LH and testosterone production bu tover time desensitize and downregulate GnRH receptors
used to treat prostate cancer
MOA degarelix
GnRH antagonist
fast onset
no LH surge
reduces LH/FSH production and release
decrease testosterone production
MOA abiraterone
androgen biosynthetic inhibitor (blocks 17alpha)
MOA finasteride and dutasteride
5 alpha reductase inhibitors
reduces DHT levels
used to treat BPH, and androgenic alopecia